JANUX THERAPEUTICS INC

Ticker: JANX CUSIP: 47103J105 Class: Common Stock

Rhenman & Partners Asset Management AB's Holding History (CIK: 0001599882)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 225,377 Value ($000) $3,110 Avg Close $23.52 Range $13.62 - $35.34
Q3 2025
Shares 100,127 Value ($000) $2,447 Avg Close $24.35 Range $21.73 - $28.39
Q2 2025
Shares 55,127 Value ($000) $1,273 Avg Close $26.35 Range $22.48 - $33.97
Q1 2025
Shares 141,627 Value ($000) $3,824 Avg Close $37.69 Range $26.39 - $61.59
Q4 2024
Shares 170,000 Value ($000) $9,102 Avg Close $52.89 Range $40.02 - $71.71
Q3 2024
Shares 106,847 Value ($000) $4,854 Avg Close $43.50 Range $34.51 - $52.23
Q2 2024
Shares 106,847 Value ($000) $4,476 Avg Close $46.95 Range $34.63 - $65.60
Q1 2024
Shares 104,500 Value ($000) $3,934 Avg Close $21.78 Range $7.79 - $58.69